ReviewCore evidence2019

Pertuzumab in the treatment of HER2-positive breast cancer: an evidence-based review of its safety, efficacy, and place in therapy.

Kei Ishii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.